Gustavo Cilla *

Autor invitado por SIIC

Conocer los factores de riesgo para la hospitalización a causa de infección por virus respiratorio sincisial facilitará la adopción de medidas preventivas

FACTORES DE RIESGO PARA HOSPITALIZACION DEBIDA A INFECCION POR VIRUS RESPIRATORIO SINCISIAL

Además de otros factores bien conocidos, en este estudio destacamos que el bajo peso al nacer fue un factor de riesgo para hospitalización a causa de infección por virus respiratorio sincisial, el factor más frecuentemente detectado. No obstante, la mayor parte de los niños hospitalizados a causa de una infección por virus respiratorio sincisial no presentaron condiciones subyacentes (80%) y en muy pocos (3%) estaría indicada la inmunoprofilaxis frente al virus respiratorio sincisial.

*Gustavo Cilla
describe para SIIC los aspectos relevantes de su trabajo
RISK FACTORS FOR HOSPITALIZATION DUE TO RESPIRATORY SYNCYTIAL VIRUS INFECTION AMONG INFANTS IN THE BASQUE COUNTRY, SPAIN
Institución principal de la investigación
*Hospital Donostia, San Sebastián, España
Imprimir nota

Comprar este artículo
Otros artículos escogidos

Referencias bibliográficas
1. Simoes EAF. Respiratory syncytial virus infection. Lancet 1999; 354:847-52.
2. Hall CB, McCarthy CA. Respiratory syncytial virus. In Mandell GL, Bennett JE, Dolin R (eds). Principles and Practice of Infectious Diseases 5th edition. Churchill Livingstone, Philadelphia, 2000 (vol 2):1782-800.
3. Leader S, Kohlhase K. Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000. J Pediatr 2003; 143:S127-S132.
4. Boyce TG, Mellen BG, Mitchell EF, Wright PF, Griffin MR. Rates of hospitalization for respiratory syncytial virus infection among children in Medicaid. J Pediatr 2000; 137:865-70.
5. Müller-Pebody B, Edmunds WJ, Zambon MC, Gay NJ, Crowcroft NS. Contribution of RSV to bronchiolitis and pneumonia-associated hospitalizations in English children, April 1995-March 1998. Epidemiol Infect 2002; 129:99-106.
6. Vicente D, Montes M, Cilla G, Pérez Yarza EG, Pérez Trallero E. Hospitalization for respiratory syncytial virus in the paediatric population in Spain. Epidemiol Infect 2003; 131:867-72.
7. American Academy of Pediatrics. Committee on Infectious Diseases and Committee on Fetus and Newborn. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infection. Pediatrics 2003; 112:1442-46.
8. Cilla G, Pérez Trallero E, Marimón JM, Erdozáin S, Gutiérrez C. Prevalence of hepatitis A antibody among disadvantaged gipsy children in northern Spain. Epidemiol Infect 1995; 115:157-61.
9. Weigl JA, Puppe W, Schmidt HJ. Incidence of respiratory syncytial virus-positive hospitalizations in Germany. Eur J Clin Microbiol Infect Dis 2001; 20:452-59.
10. Kristensen K, Dahm T, Frederiksen PS, Ibsen J, Iyore E, Jensen AM, Kjaer BB, Olofsson K, Pedersen P, Poulsen S. Epidemiology of respiratory syncytial virus infection requiring hospitalization in East Denmark. Pediatr Infec Dis J 1998; 17:996-1000.
11. Kaneko M, Watanabe J, Kuwahara M, Ueno E, Hida M, Kinoshita A, Sone T. Impact of respiratory syncytial virus infection as a cause of lower respiratory tract infection in children younger than 3 years of age in Japan. J Infec 2002; 44:240-243.
12. Willson DF, Landrigan CP, Horn SD, Smout RJ. Complications in infants hospitalised for bronchiolitis or respiratory syncytial virus pneumonia. J Pediatr 2003; 143:S142-S149.
13. MacDonald NE, Hall CB, Suffin SC, Alexson C, Harris PJ, Manning JA. Respiratory syncytial viral infection in infants with congenital heart disease. N Engl J Med 1982; 307:397-400.
14. Nielsen HE, Siersma V, Andersen S, Gahrn-Hansen B, Mordhorst CH, Norgaard-Pedersen B, Roder B, Sorensen TL, Temme R, Vestergaard BF. Respiratory syncytial virus infection-risk factors for hospital admission: a case-control study. Acta Paediatr 2003; 92:1314-21.
15. Lacaze-Masmonteil T, Truffert P, Pinquier D, Daoud P, Goldfarb G, Vicaut E, Fauroux B. Lower respiratory tract illness and RSV prophylaxis in very premature infants. Arch Dis Child 2004; 89:562-67.
16. Law BJ, Langley JM, Allen U, Paes B, Lee DSC, Mitchell I, Sampalis J et al. The Pediatric Investigators Collaborative Network on infections in Canada study of predictors of hospitalisation for respiratory syncytial virus infection for infants born at 33 through 35 completed weeks of gestation. Pediatr Infect Dis J 2004; 23:806-14.
17. Holman RC, Shay DK, Curns AT, Lingappa JR, Anderson LJ. Risk factors for bronchiolitis-associated deaths among infants in the United States. Pediatr Infect Dis J 2003; 22:483-89.
18. Prais D, Schonfeld T, Amir J, for the Israeli RSV monitoring group. Admission to the Intensive care unit for respiratory syncytial virus bronchiolitis: a national survey before palivizumab use. Pediatrics 2003; 112:548-552.

Otros artículos de Gustavo Cilla

1. Cilla G, Pérez Trallero E, López Lopategui C, Gil Setas A, Gomáriz M. Incidence, seasonality and serotypes of rotavirus in Gipuzkoa (Basque Country), Spain. A forteen-year study. Epidemiology and Infection 2000; 125:677-83.
2. Cilla G, Rodes B, Pérez Trallero E, Arrizabalaga J, Soriano V. Molecular evidence of homosexual transmission of HIV type 2 in Spain. AIDS Research and Human Retroviruses 2001; 17:417-422.
3. Montes M, Cilla G, Artieda J, Vicente D, Basterretxea M. Mumps outbreak in vaccinated children in Gipuzkoa (Basque Country), Spain. Epidemiology and Infection 2002; 129:551-6.
4. Vicente D, Cilla G, Montes M, Pérez Trallero E. Human metapneumovirus and community-acquired respiratory illness in children. Emerging Infectious Diseases 2003; 9:602-3.
5. Vicente D, Montes M, Cilla G, Pérez Yarza EG, Pérez Trallero E. Hospitalization for respiratory syncytial virus in the paediatric population in Spain. Epidemiology and Infection 2003; 131:867-872.
6. Cilla G, Basterretxea M, Artieda J, Vicente D, Pérez Trallero E. Interruption of measles transmission in Gipuzkoa (Basque Country) Spain. Eurosurveillance 2004; 9:7-8.
7. Cilla G, Dorronsoro M, Sáenz Domínguez JR, Serrano E, Pérez Trallero E. Increase of immunity to rubella and interruption of rubella transmission in Gipuzkoa (Basque Country, Spain) after an enhanced vaccination program. Epidemiology and Infection 2004; 132:685-692.
8. Arostegi Kareaga N, Montes M, Pérez Yarza EG, Sardon O, Vicente D, Gilla G. Caracteristicas clinicas de los niños hospitalizados por infección debida a virus influenza. Anales de Pediatría (Barc) 2005; 62:5-12.
9. Montes M, Vicente D, Pérez Yarza EG, Cilla G, Pérez Trallero E. Influenza-related hospitalisations among children aged less than 5 years old in the Basque Country, Spain: a 3-year study (July 2001-June 2004). Vaccine 2005; 23:4302-4306.
10. Vicente D, Montes M, Cilla G, Pérez Yarza EG, Pérez Trallero E. Differences in clinical severity between genotype A and genotype B human metapneumovirus infection in children. Clinical Infectious Diseases 2006; 42:e111-113.

Para comunicarse con Gustavo Cilla mencionar a SIIC como referencia:
ludserol

---

Acerca del trabajo completo

FACTORES DE RIESGO PARA HOSPITALIZACION DEBIDA A INFECCION POR VIRUS RESPIRATORIO SINCISIAL

Título original en castellano
FACTORES DE RIESGO PARA HOSPITALIZACION DEBIDA A INFECCION POR VIRUS RESPIRATORIO SINCITIAL EN NIÑOS MENORES DE 2 AÑOS EN EL PAIS VASCO, ESPAÑA

Autor


Acceso a la fuente original
Epidemiology and Infection
http://journals.cambridge.org/journal_EpidemiologyandInfection

El artículo se relaciona estrictamente con las especialidades de siicsalud
El artículo se conecta secundariamente con las especialidades